Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-centre Study to Evaluate the Diagnostic Sensitivity and Specificity of the Determine™ Syphilis Advanced Test.

NCT06584214 is registered in ClinicalTrials.gov with Abbott Rapid Dx as lead sponsor.

NCT NCT06584214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06584214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-centre Study to Evaluate the Diagnostic Sensitivity and Specificity of the Determine™ Syphilis Advanced Test.
Lead sponsor
Abbott Rapid Dx
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2024
Completion date
December 31, 2024
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

syphilis infection